Abstract
Metabolic syndrome (MetS) and obstructive sleep apnea (OSA) are related to a higher incidence of cardio-vascular diseases and mortality in patients. The aim of the study was to define the potential use of anthropometric factors for the evaluation of OSA risk in patients with diagnosed MetS. The patient group consisted of 50 obese men with MetS (mean age 49 ± 9 years). The following anthropometric indices were assessed: body mass index (BMI), neck circumference (NC), waist circumference (WC), and waist-to-hip ratio (WHR). In addition, blood glucose and lipid profile were investigated. On the basis of polysomnography, clinical symptoms, and Epworth Sleep Scale, patients were stratified into the OSA group accompanied by MetS (n = 31) and the MetS alone group taken as control (n = 19). OSA was evaluated as severe in 26 out of the 31 patients (>30 apneic episodes per hour). We found a significantly larger NC in the OSA with MetS group then that in the MetS alone group. Further, NC associated with the increase in the apnea/hypopnea index. However, the other anthropometric indices investigated failed to differentiate the two groups. We conclude that increased neck circumference in patients suffering from metabolic syndrome is a risk factor for the development of OSA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AASM (2014) American Academy of Sleep Medicine. International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A (1998) Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144–148
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela–Bueno A, Kales A (2001) Prevalence of sleep–disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163:608–613
Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela–Bueno A, Kales A (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90:4510–4515
Bonsignore MR, Borel AL, Machan E, Grunstein R (2013) Sleep and breathing. Eur Respir Rev 22:353–364
Cizza G, de Jonge L, Piaggi P, Mattingly M, Zhao X, Lucassen E, Rother KI, Sumner AE, Csako G, NIDDK Sleep Extension Study (2014) Neck circumference is a predictor of metabolic syndrome and obstructive sleep apnea in short–sleeping obese men and women. Metab Syndr Relat Disord 12:231–241
Coughlin S, Calverley P, Wilding J (2001) Sleep disordered breathing – a new component of syndrome x? Obes Rev 2:267–274
Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741
Davies JO, Ali NJ, Stradling JR (1992) Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 47:101–105
Deegan PC, McNicholas WT (1995) Pathophysiology of obstructive sleep apnoea. Eur Respir J 8:1161–1178
Drager LF, Queiroz EL, Lopes HF, Genta PR, Krieger EM, Lorenzi–Filho G (2009) Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome. J Cardiometab Syndr 4:89–95
Drager LF, Lopes HF, Maki–Nunes C, Trombetta IC, Toschi–Dias E, Alves MJ, Fraga RF, Jun JC, Negrão CE, Krieger EM, Polotsky VY, Lorenzi–Filho G (2010) The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 5(8):e12065
Drager LF, Polotsky VY, O’Donnell CP, Cravo SL, Lorenzi–Filho G, Machado BH (2015) Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol 309(7):H1101–H1111
Flemons WW, Whitelaw WA, Brant R, Remmers JE (1994) Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 150(Pt 1):1279–1285
Formiguera X, Canton A (2004) Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 18:1125–1146
Gaines J, Vgontzas AN, Fernandez–Mendoza J, Bixler EO (2018) Obstructive sleep apnea and the metabolic syndrome: the road to clinically–meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev 42:211–219
Gami AS, Somers VK (2004) Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 25:709–711
Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22
Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231–237
Jaspinder K (2014) A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162
Kritikou I, Basta M, Tappouni R, Pejovic S, Fernandez–Mendoza J, Nazir R, Shaffer ML, Liao D, Bixler EO, Chrousos GP, Vgontzas AN (2013) Sleep apnoea and visceral adiposity in middle–aged male and female subjects. Eur Respir J 41:601–609
Kritikou I, Basta M, Vgontzas AN, Pejovic S, Liao D, Tsaoussoglou M, Bixler EO, Stefanakis Z, Chrousos GP (2014) Sleep apnoea, sleepiness, inflammation and insulin resistance in middle aged males and females. Eur Respir J 43:145–155
Lubrano C, Saponara M, Barbaro G, Specchia P, Addessi E, Costantini D, Tenuta M, Di Lorenzo G, Genovesi G, Donini LM, Lenzi A, Gnessi L (2012) Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One 7:e47059
Lui MM, Lam JC, Mak HK, Xu A, Ooi C, Lam DC, Mak JC, Khong PL, Ip MS (2009) C–reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 135:950–956
Peppard PE, Young T, Palta M, Dempsey J, Skatrud J (2000) Longitudinal study of moderate weight change and sleep–disordered breathing. JAMA 284:3015–3021
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep–disordered breathing in adults. Am J Epidemiol 177:1006–1014
Pływaczewski R, Brzecka A, Bielicki P, Czajkowska–Malinowska M, Cofta S, Jonczak L, Radliński J, Tażbirek M, Wasilewska J, Polish Society of Lung Diseases (2013) Sleep related breathing disorders in adults – recommendations of Polish Society of Lung Diseases. Pneumonol Alergol Pol 81(3):221–258. (Article in Polish)
Poelkens F, Lammers G, Pardoel EM, Tack CJ, Hopman MT (2013) Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome. Exp Physiol 98:1485–1494
Qian Y, Xu H, Wang Y, Yi H, Guan J, Yin S (2016) Obstructive sleep apnea predicts risk of metabolic syndrome independently of obesity: a meta–analysis. Arch Med Sci 12(5):1077–1087
Ridker PM, Buring JE, Cook NR, Rifai N (2003) C–reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8–year followup of 14 719 initially healthy American women. Circulation 107:391–397
Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906–1914
Soylu AC, Levent E, Sariman N, Yurtlu S, Alparslan S, Saygı A (2012) Obstructive sleep apnea syndrome and anthropometric obesity indexes. Sleep Breath 16:1151–1158
Stabe C, Vasques AC, Lima MM, Tambascia MA, Pareja JC, Yamanaka A, Geloneze B (2013) Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clin Endocrinol 78:874–881
Tażbirek M, Słowińska L, Kawalski M, Pierzchała W (2011) The rheological properties of blood and the risk of cardiovascular disease in patients with obstructive sleep apnea syndrome (OSAS). Folia Histochem Cytobiol 49:206–210
Venkateswaran S, Shankar P (2007) The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore. Postgrad Med J 83:329–331
Vgontzas AN (2008) Excessive daytime sleepiness in sleep apnea: it is not justapnea hypopnea index. Sleep Med 9:712–714
Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158
Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224
Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697e738
Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE (1998) “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53(Suppl 3):S25–S28
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep–disordered breathing among middle–aged adults. N Engl J Med 328:1230–1235
Conflicts of interest
The authors declare no conflicts of interest in relation to this article.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of Medical University of Silesia.
Consent
Written informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tażbirek, M., Potoczny, J., Strójwąs, K., Pierzchała, W., Barczyk, A. (2019). Anthropometric Factors in the Assessment of Obstructive Sleep Apnea Risk in Patients with Metabolic Syndrome. In: Pokorski, M. (eds) Advances in Pulmonary Medicine: Research and Innovations. Advances in Experimental Medicine and Biology(), vol 1160. Springer, Cham. https://doi.org/10.1007/5584_2019_376
Download citation
DOI: https://doi.org/10.1007/5584_2019_376
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21098-4
Online ISBN: 978-3-030-21099-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)